Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Jun;13(6):975–978. doi: 10.1128/aac.13.6.975

Combination of Pentamidine and Trimethoprim-Sulfamethoxazole in the Therapy of Pneumocystis carinii Pneumonia in Rats

Ronica M Kluge 1, David M Spaulding 2, Alan J Spain 2
PMCID: PMC352374  PMID: 307941

Abstract

Treatment with either pentamidine isethionate or trimethoprim-sulfamethoxazole significantly reduces the mortality of Pneumocystis carinii pneumonia. It is not known whether a combination might act in an additive, synergistic, or antagonistic manner. We studied the interaction of these two agents in the steroid-conditioned rat model of pneumocystosis. Of animals receiving pentamidine alone, 48% died and 45% had P. carinii cysts at autopsy. Trimethoprim-sulfamethoxazole alone resulted in 21% mortality, and cysts were found in 28%. Both agents in full doses resulted in 45% deaths and cysts in 37%. Animals treated with half-dosages of pentamidine plus trimethroprim-sulfamethoxazole had mortality of 35%, and 21% had cysts. Trimethoprim alone, in two dosages, was ineffective in eradicating P. carinii cysts. The data suggest that combination therapy is no more effective than trimethoprim-sulfamethoxazole alone in the treatment of P. carinii pneumonia.

Full text

PDF
976

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Frenkel J. K., Good J. T., Shultz J. A. Latent Pneumocystis infection of rats, relapse, and chemotherapy. Lab Invest. 1966 Oct;15(10):1559–1577. [PubMed] [Google Scholar]
  2. Goodell B., Jacobs J. B., Powell R. D., DeVita V. T. Pneumocystis carinii: the spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. Ann Intern Med. 1970 Mar;72(3):337–340. doi: 10.7326/0003-4819-72-3-337. [DOI] [PubMed] [Google Scholar]
  3. Hughes W. T. Editorial: Treatment of Pneumocystis carinii pneumonitis. N Engl J Med. 1976 Sep 23;295(13):726–727. doi: 10.1056/NEJM197609232951311. [DOI] [PubMed] [Google Scholar]
  4. Hughes W. T., Kim H. K., Price R. A., Miller C. Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp. 1973 Aug;15(8):581–587. [PubMed] [Google Scholar]
  5. Hughes W. T., McNabb P. C., Makres T. D., Feldman S. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother. 1974 Mar;5(3):289–293. doi: 10.1128/aac.5.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. IVADY G., PALDY L. Ein neues Behandlungsverfahren der interstitiellen plasmazelligen Pneumonie Frühgeborener mit fünfwertigem Stibium und aromatischen Diamidinen. Monatsschr Kinderheilkd. 1958 Jan;106(1):10–14. [PubMed] [Google Scholar]
  7. Johnson H. D., Johnson W. W. Pneumocystic carinii pneumonia in children with cancer. Diagnosis and treatment. JAMA. 1970 Nov 9;214(6):1067–1073. [PubMed] [Google Scholar]
  8. Kirby H. B., Kenamore B., Guckian J. C. Pneumocystis carinii pneumonia treated with pyrimethamine and sulfadiazine. Ann Intern Med. 1971 Oct;75(4):505–509. doi: 10.7326/0003-4819-75-4-505. [DOI] [PubMed] [Google Scholar]
  9. Lau W. K., Young L. S., Remington J. S. Pneumocystis carinii pneumonia. Diagnosis by examination of pulmonary secretions. JAMA. 1976 Nov 22;236(21):2399–2402. doi: 10.1001/jama.236.21.2399. [DOI] [PubMed] [Google Scholar]
  10. Lau W. K., Young L. S. Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med. 1976 Sep 23;295(13):716–718. doi: 10.1056/NEJM197609232951308. [DOI] [PubMed] [Google Scholar]
  11. Le Clair R. A. Descriptive epidemiology of interstitial pneumocystic pneumonia. An analysis of 107 cases from the United States, 1955-1967. Am Rev Respir Dis. 1969 Apr;99(4):542–547. doi: 10.1164/arrd.1969.99.4P1.542. [DOI] [PubMed] [Google Scholar]
  12. Rifkind D., Faris T. D., Hill R. B., Jr Pneumocystis carinii pneumonia. Studies on the diagnosis and treatment. Ann Intern Med. 1966 Nov;65(5):943–956. doi: 10.7326/0003-4819-65-5-943. [DOI] [PubMed] [Google Scholar]
  13. Rosen P. P., Martini N., Armstrong D. Pneumocystis carinii pneumonia. Diagnosis by lung biopsy. Am J Med. 1975 Jun;58(6):794–802. doi: 10.1016/0002-9343(75)90634-8. [DOI] [PubMed] [Google Scholar]
  14. Walzer P. D., Perl D. P., Krogstad D. J., Rawson P. G., Schultz M. G. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974 Jan;80(1):83–93. doi: 10.7326/0003-4819-80-1-83. [DOI] [PubMed] [Google Scholar]
  15. Western K. A., Norman L., Kaufmann A. G. Failure of pentamidine isethionate to provide chemoprophylaxis against Pneumocytis carinii infection in rats. J Infect Dis. 1975 Mar;131(3):273–276. doi: 10.1093/infdis/131.3.273. [DOI] [PubMed] [Google Scholar]
  16. Western K. A., Perera D. R., Schultz M. G. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med. 1970 Nov;73(5):695–702. doi: 10.7326/0003-4819-73-5-695. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES